These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 9311709)

  • 1. Cytomegalovirus viremia: risk factor for allograft cirrhosis after liver transplantation for hepatitis C.
    Rosen HR; Chou S; Corless CL; Gretch DR; Flora KD; Boudousquie A; Orloff SL; Rabkin JM; Benner KG
    Transplantation; 1997 Sep; 64(5):721-6. PubMed ID: 9311709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C.
    Burak KW; Kremers WK; Batts KP; Wiesner RH; Rosen CB; Razonable RR; Paya CV; Charlton MR
    Liver Transpl; 2002 Apr; 8(4):362-9. PubMed ID: 11965581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of cytomegalovirus viraemia on the outcome of recurrent hepatitis C after liver transplantation.
    Teixeira R; Pastacaldi S; Davies S; Dhillon AP; Emery VC; Rolles K; Davidson B; Patch D; Burroughs AK
    Transplantation; 2000 Nov; 70(10):1454-8. PubMed ID: 11118089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of cytomegalovirus infection and disease with recurrent hepatitis C after liver transplantation.
    Bosch W; Heckman MG; Pungpapong S; Diehl NN; Shalev JA; Hellinger WC
    Transplantation; 2012 Apr; 93(7):723-8. PubMed ID: 22406819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Cytomegalovirus Infection on Severe Hepatitis C Recurrence in Patients Undergoing Liver Transplantation.
    Caston JJ; Castells L; Varo E; Gomez MA; de la Mata M; Campos-Varela I; Lumbreras C; Gonzalez-Dieguez L; Fabregat J; Herrero I; Salcedo M; Sanchez-Antolín G; Torre-Cisneros J
    Transplantation; 2016 Mar; 100(3):593-9. PubMed ID: 26371595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indirect outcomes associated with cytomegalovirus (opportunistic infections, hepatitis C virus sequelae, and mortality) in liver-transplant recipients with the use of preemptive therapy for 13 years.
    Singh N; Wannstedt C; Keyes L; Wagener MM; Gayowski T; Cacciarelli TV
    Transplantation; 2005 May; 79(10):1428-34. PubMed ID: 15912115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late cytomegalovirus infection in children: High incidence of allograft rejection and hepatitis in donor negative and seropositive liver transplant recipients.
    Verma A; Palaniswamy K; Cremonini G; Heaton N; Dhawan A
    Pediatr Transplant; 2017 May; 21(3):. PubMed ID: 28134467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the bidirectional interactions between human cytomegalovirus and hepatitis C virus replication after liver transplantation.
    Nebbia G; Mattes FM; Cholongitas E; Garcia-Diaz A; Samonakis DN; Burroughs AK; Emery VC
    Liver Transpl; 2007 Jan; 13(1):130-5. PubMed ID: 17192909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of oral acyclovir or ganciclovir therapy after preemptive intravenous ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus seropositive renal and liver transplant recipients receiving antilymphocyte antibody therapy.
    Turgeon N; Fishman JA; Basgoz N; Tolkoff-Rubin NE; Doran M; Cosimi AB; Rubin RH
    Transplantation; 1998 Dec; 66(12):1780-6. PubMed ID: 9884276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Timing and severity of initial hepatitis C recurrence as predictors of long-term liver allograft injury.
    Rosen HR; Gretch DR; Oehlke M; Flora KD; Benner KG; Rabkin JM; Corless CL
    Transplantation; 1998 May; 65(9):1178-82. PubMed ID: 9603164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of cytomegalovirus genotype with graft rejection after liver transplantation.
    Rosen HR; Corless CL; Rabkin J; Chou S
    Transplantation; 1998 Dec; 66(12):1627-31. PubMed ID: 9884250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of early EBV and/or CMV viremia on graft function and acute cellular rejection in pediatric liver transplantation.
    Indolfi G; Heaton N; Smith M; Mieli-Vergani G; Zuckerman M
    Clin Transplant; 2012; 26(1):E55-61. PubMed ID: 21981027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes.
    Prieto M; Berenguer M; Rayón JM; Córdoba J; Argüello L; Carrasco D; García-Herola A; Olaso V; De Juan M; Gobernado M; Mir J; Berenguer J
    Hepatology; 1999 Jan; 29(1):250-6. PubMed ID: 9862874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of interferon treatment on liver histology and allograft rejection in patients with recurrent hepatitis C following liver transplantation.
    Stravitz RT; Shiffman ML; Sanyal AJ; Luketic VA; Sterling RK; Heuman DM; Ashworth A; Mills AS; Contos M; Cotterell AH; Maluf D; Posner MP; Fisher RA
    Liver Transpl; 2004 Jul; 10(7):850-8. PubMed ID: 15237368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytomegalovirus reactivation in liver transplant recipients due to hepatitis C cirrhosis is associated with higher cardiovascular risk - an observational, retrospective study.
    Aguilera V; Di Maira T; Conde I; Fornés-Ferrer V; Vinaixa C; Pallarés C; Carvalho-Gomes A; Cubells A; García M; Rubín Á; Benlloch S; Gonzalez-Dieguez L; Molina JM; Puchades L; López-Labrador FX; Prieto M; Berenguer M
    Transpl Int; 2018 Jun; 31(6):649-657. PubMed ID: 29493818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcome of hepatitis C infection after liver transplantation.
    Gane EJ; Portmann BC; Naoumov NV; Smith HM; Underhill JA; Donaldson PT; Maertens G; Williams R
    N Engl J Med; 1996 Mar; 334(13):815-20. PubMed ID: 8596547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human herpesvirus 6 in donor biopsies associated with the incidence of clinical cytomegalovirus disease and hepatitis C virus recurrence.
    Guardia AC; Stucchi RS; Sampaio AM; Milan A; Costa SC; Pavan CR; Boin Ide F
    Int J Infect Dis; 2012 Feb; 16(2):e124-9. PubMed ID: 22178541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytomegalovirus infection in living donor liver transplant recipients significantly impacts the early post-transplant outcome: A single center experience.
    Yadav SK; Saigal S; Choudhary NS; Saha S; Sah JK; Saraf N; Kumar N; Goja S; Rastogi A; Bhangui P; Soin AS
    Transpl Infect Dis; 2018 Aug; 20(4):e12905. PubMed ID: 29668120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed-onset primary cytomegalovirus disease after liver transplantation.
    Arthurs SK; Eid AJ; Pedersen RA; Dierkhising RA; Kremers WK; Patel R; Razonable RR
    Liver Transpl; 2007 Dec; 13(12):1703-9. PubMed ID: 18044717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of cytomegalovirus viremia on subclinical rejection or interstitial fibrosis and tubular atrophy in protocol biopsy at 3 months in renal allograft recipients managed by preemptive therapy or antiviral prophylaxis.
    Reischig T; Jindra P; Hes O; Bouda M; Kormunda S; Treska V
    Transplantation; 2009 Feb; 87(3):436-44. PubMed ID: 19202451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.